Intellia Therapeutics, Inc. (NTLA)
9.085
-0.06
(-0.60%)
USD |
NASDAQ |
Dec 30, 11:14
Intellia Therapeutics EPS Diluted (Quarterly): -0.9196 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.133 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Beam Therapeutics, Inc. | -1.099 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| Pacific Biosciences of California, Inc. | -0.1263 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -101.32M |
| Revenue (Quarterly) | 13.78M |
| Total Expenses (Quarterly) | 115.11M |
| Enterprise Value | 645.61M |
| Gross Profit Margin (Quarterly) | 64.19% |
| Profit Margin (Quarterly) | -735.2% |
| Earnings Yield | -46.95% |
| Normalized Earnings Yield | -46.42 |